Monday - October 26, 2026

Selective Cyclin-Dependent Kinase Inhibitors and Methods of Therapeutic Use Thereof

2026-10-13

ALEXANDRIA, Virginia, Oct. 13 -- VIROKYNE THERAPEUTICS, LLC, Raleigh, North Carolina has been assigned a patent (No. US 12760025 B2, initially filed Jan. 28, 2022) developed by William J. Zuercher, Mies, Switzerland, and Nathaniel J. Moorman, Chapel Hill, North Carolina, for "Selective cyclin-dependent kinase inhibitors and methods of therapeutic use thereof." . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Selective Cyclin-Dependent Kinase Inhibitors and Methods of Therapeutic Use Thereof

Information Request Form

Copyright Targeted News Service 2026